The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Primary Biliary Cirrhosis
Abstract
This chapter contains sections titled: Introduction Diagnosis Natural history Surrogate markers of outcome Therapeutic trial design: assessment of credibility Randomized controlled trials of treatment for primary biliary cirrhosis The future for therapy in primary biliary cirrhosis References
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Self-citationBiochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Corpechot, C., Abenavoli, L., Rabahi, N., Chrétien, Y., Andréani, T., Johanet, C., Chazouillères, O., & Poupon, R. (2008) · Hepatology · doi:10.1002/hep.22428 · Cited by 646
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594
Self-citationIS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?
Poupon, R., Poupon, R., Calmus, Y., Chrétien, Y., Ballet, F., & Darnis, F. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91610-2 · Cited by 536
SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS
WALKER, J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91372-3 · Cited by 507
The presentation and diagnosis of 100 patients with primary biliary cirrhosis
Sherlock, S., & Scheuer, P. J. (1973) · New England Journal of Medicine · doi:10.1056/nejm197309272891306 · Cited by 504
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Christensen, E., Neuberger, J., Crowe, J., Altman, D. G., Popper, H., Portmann, B., Doniach, D., Ranek, L., Tygstrup, N., & Williams, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90213-6 · Cited by 423
Natural history of early primary biliary cirrhosis
Metcalf, J. V., Mitchison, H. C., Palmer, J. M., Jones, D. E., Bassendine, M. F., & James, O. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04410-8 · Cited by 421
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
Beuers, U. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0521 · Cited by 417
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
Corpechot, C., Carrat, F., Bahr, A., Chrétien, Y., Poupon, R.-E., & Poupon, R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.009 · Cited by 390
Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology · doi:10.1002/hep.21472 · Cited by 365
Prince, M., Chetwynd, A., Newman, W., Metcalf, J. V., & James, O. F. W. (2002) · Gastroenterology · doi:10.1053/gast.2002.36027 · Cited by 348
Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
Wolfhagen, F., Sternieri, E., Hop, W., Vitale, G., Bertolotti, M., & Van Buuren, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322521 · Cited by 343
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Sertraline as a first-line treatment for cholestatic pruritus
Mayo, M. J., Handem, I., Saldana, S., Jacobe, H., Getachew, Y., & Rush, J. A. (2007) · Hepatology · doi:10.1002/hep.21553 · Cited by 329
Serum bilirubin: a prognostic factor in primary biliary cirrhosis
Shapiro, J. M., Smith, H., & Schaffner, F. (1979) · Gut · doi:10.1136/gut.20.2.137 · Cited by 319
Corpechot, C., Carrat, F., Bonnand, A.-M., Poupon, R. E., & Poupon, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20240 · Cited by 316
Goulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315
A Prospective Trial of Colchicine for Primary Biliary Cirrhosis
Kaplan, M. M., Alling, D. W., Zimmerman, H. J., Wolfe, H. J., Sepersky, R. A., Hirsch, G. S., Elta, G. H., Glick, K. A., & Eagen, K. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152304 · Cited by 313
Fickert, P., Wagner, M., Marschall, H., Fuchsbichler, A., Zollner, G., Tsybrovskyy, O., Zatloukal, K., Liu, J., Waalkes, M. P., Cover, C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.018 · Cited by 300
A controlled trial of naloxone infusions for the pruritus of chronic cholestasis
Bergasa, N. V., Talbot, T. L., Alling, D. W., Schmitt, J. M., Walker, E. C., Baker, B. L., Korenman, J. C., Park, Y., Hoofnagle, J. H., & Jones, E. A. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90102-5 · Cited by 287
The causes of primary biliary cirrhosis: Convenient and inconvenient truths
Gershwin, E. M., & Mackay, I. R. (2008) · Hepatology · doi:10.1002/hep.22042 · Cited by 274
Parés, A., Caballería, L., Rodés, J., Bruguera, M., Rodrigo, L., García-Plaza, A., Berenguer, J., Rodríguez-Martínez, D., Mercader, J., & Velicia, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80216-0 · Cited by 271
COMBES, B. (1995) · Hepatology · doi:10.1016/0270-9139(95)90294-5 · Cited by 268
Jacoby, A., Rannard, A., Buck, D., Bhala, N., Newton, J. L., James, O. F. W., & Jones, D. E. J. (2005) · Gut · doi:10.1136/gut.2005.065862 · Cited by 267
Prince, M. I., Chetwynd, A., Craig, W. L., Metcalf, J. V., & James, O. F. W. (2004) · Gut · doi:10.1136/gut.2003.023937 · Cited by 261
Leuschner, M., Maier, K., Schlichting, J., Strahl, S., Herrmann, G., Dahm, H. H., Ackermann, H., Happ, J., & Leuschner, U. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70351-3 · Cited by 247
Kondrackiene, J., Beuers, U., & Kupcinskas, L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.019 · Cited by 247
Fatigue in primary biliary cirrhosis
Cauch-Dudek, K., Abbey, S., Stewart, D. E., & Heathcote, E. J. (1998) · Gut · doi:10.1136/gut.43.5.705 · Cited by 237
Self-citationPrimary Biliary Cirrhosis: Prediction of Short–Term Survival Based on Repeated Patient Visits
Murtaugh, P. A., Dickson, R. E., Van Dam, G. M., Malinchoc, M., Grambsch, P. M., Langworthy, A. L., & Gips, C. H. (1994) · Hepatology · doi:10.1002/hep.1840200120 · Cited by 236
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis
Lindor, K., Therneau, T., Jorgensen, R., Malinchoc, M., & Dickson, E. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613058 · Cited by 228
Rautiainen, H., Kärkkäinen, P., Karvonen, A., Nurmi, H., Pikkarainen, P., Nuutinen, H., & Färkkilä, M. (2005) · Hepatology · doi:10.1002/hep.20646 · Cited by 222
Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice).
Sherlock, S. (1959) · PubMed · Cited by 218
Poupon, R. E., Lindor, K. D., Parés, A., Chazouillères, O., Poupon, R., & Heathcote, E. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00192-2 · Cited by 217
Self-citationA Controlled Trial of Cyclosporine in the Treatment of Primary Biliary Cirrhosis
Wiesner, R. H., Ludwig, J., Lindor, K. D., Jorgensen, R. A., Baldus, W. P., Homburger, H. A., & Dickson, E. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222003 · Cited by 212
Newton, J. L., Jones, D. E. J., Henderson, E., Kane, L., Wilton, K., Burt, A. D., & Day, C. P. (2008) · Gut · doi:10.1136/gut.2007.139303 · Cited by 201
Primary Biliary Cirrhosis (Chronic Intrahepatic Obstructive Jaundice)
Sherlock, S. (1959) · Gastroenterology · doi:10.1016/s0016-5085(19)35377-6 · Cited by 200
A controlled trial of prednisolone treatment in primary biliary cirrhosis
Mitchison, H. C., Palmer, J. M., Bassendine, M. F., Watson, A. J., Record, C. O., & James, O. F. W. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90065-w · Cited by 199
Time course of histological progression in primary biliary cirrhosis
Locke, G. R., Therneau, T. M., Ludwig, J., Dickson, E. R., & Lindor, K. D. (1996) · Hepatology · doi:10.1002/hep.510230108 · Cited by 184
Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis
Datta, D. V., & Sherlock, S. (1966) · Gastroenterology · doi:10.1016/s0016-5085(66)80071-9 · Cited by 181
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression
Menon, K. V. N., Angulo, P., Weston, S., Dickson, E. R., & Lindor, K. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00144-1 · Cited by 180
Charatcharoenwitthaya, P., Pimentel, S., Talwalkar, J. A., Enders, F. T., Lindor, K. D., Krom, R. A. F., & Wiesner, R. H. (2007) · Liver Transplantation · doi:10.1002/lt.21124 · Cited by 179
Angulo, P., Jorgensen, R. A., Keach, J. C., Dickson, R. E., Smith, C., & Lindor, K. D. (2000) · Hepatology · doi:10.1002/hep.510310209 · Cited by 179
Tandon, P., Rowe, B. H., Vandermeer, B., & Bain, V. G. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01200.x · Cited by 176
Leuschner, U., Leuschner, M., Sieratzki, J., Kurtz, W., & H�bner, K. (1985) · Digestive Diseases and Sciences · doi:10.1007/bf01308413 · Cited by 176
Corpechot, C., Carrat, F., Poupon, R., & Poupon, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.31880 · Cited by 169
Oertelt, S., Rieger, R., Selmi, C., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S. C., & Gershwin, E. M. (2007) · Hepatology · doi:10.1002/hep.21583 · Cited by 168
Trial of Penicillamine in Advanced Primary Biliary Cirrhosis
Dickson, E. R., Fleming, T. R., Wiesner, R. H., Baldus, W. P., Fleming, C. R., Ludwig, J., & McCall, J. T. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504183121602 · Cited by 165
Mahl, T. C., Shockcor, W., & Boyer, J. L. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80139-4 · Cited by 163
Lombard, M. G., Portmann, B. C., Neuberger, J., Williams, R. L., Tygstrup, N., Ranek, L., Ring‐Larsen, H., Rodés, J., Navasa, M., TREPO, C. G., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90422-9 · Cited by 163
Khurana, S., & Singh, P. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01326.x · Cited by 162
ter Borg, P. C. J., Schalm, S. W., Hansen, B. E., & van Buuren, H. R. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00699.x · Cited by 160
A Prospective Controlled Trial of Azathioprine in Primary Biliary Cirrhosis
Heathcote, J., Ross, A., & Sherlock, S. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80250-8 · Cited by 159
Randomized trial of chlorambucil for primary biliary cirrhosis
Hoofnagle, J. H., Davis, G. L., Schafer, D. F., Peters, M., Avigan, M. I., Pappas, S. C., Hanson, R. G., Minuk, G. Y., Dusheiko, G. M., Campbell, G., et al. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90183-6 · Cited by 157
Hepatology may have problems with putative surrogate outcome measures
Gluud, C. N., Brok, J. S., Gong, Y., & Koretz, R. L. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.003 · Cited by 148
Transplantation trends in primary biliary cirrhosis
Lee, J., Belanger, A., Doucette, J. T., Stanca, C., Friedman, S., & Bach, N. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.07.015 · Cited by 147
Characterization of antimitochondrial antibodies in healthy adults
Mattalia, A., Quaranta, S., Leung, P. S. C., Bauducci, M., Van de Water, J., Calvo, P. L., Danielle, F., Rizzetto, M., Ansari, A., Coppel, R. L., et al. (1998) · Hepatology · doi:10.1002/hep.510270303 · Cited by 146
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis
O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., & Heathcote, E. J. (2008) · Hepatology · doi:10.1002/hep.22380 · Cited by 146
Self-citationA controlled trial of colchicine in primary biliary cirrhosis
Warnes, T. W., Smith, A., Lee, F. I., Haboubi, N. Y., Johnson, P. J., & Hunt, L. P. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80053-3 · Cited by 145
Iwasaki, S., Ohira, H., Nishiguchi, S., Zeniya, M., Kaneko, S., Onji, M., Ishibashi, H., Sakaida, I., Kuriyama, S., Ichida, T., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00305.x · Cited by 145
Zein, C. O., Jorgensen, R. A., Clarke, B., Wenger, D. E., Keach, J. C., Angulo, P., & Lindor, K. D. (2005) · Hepatology · doi:10.1002/hep.20866 · Cited by 142
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis
Springer, J., Cauch-Dudek, K., O'Rourke, K., Wanless, I. R., & Heathcote, E. J. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.00770.x · Cited by 141
Self-citationDiminished survival in asymptomatic primary biliary cirrhosis
Balasubramaniam, K., Grambsch, P. M., Wiesner, R. H., Lindor, K. D., & Dickson, E. R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91091-j · Cited by 141
Presentation and course of asymptomatic primary biliary cirrhosis
Long, R. G., Scheuer, P. J., & Sherlock, S. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80011-5 · Cited by 140
Shi, J. Q., Wu, C., Lin, Y., Chen, Y.-X., Zhu, L., & Xie, W.-F. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00634.x · Cited by 140
Angulo, P., Dickson, E. R., Therneau, T. M., Jorgensen, R. A., Smith, C., DeSotel, C. K., Lange, S. M., Anderson, M. L., Mahoney, D. W., & Lindor, K. D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80136-6 · Cited by 134
Evaluation of colchicine therapy in primary biliary cirrhosis
Bodenheimer, H. C., Schaffner, F., & Pezzullo, J. C. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90300-9 · Cited by 133
Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference?
Lindor, K. D., Janes, C. H., Crippin, J. S., Jorgensen, R. A., & Dickson, R. E. (1995) · Hepatology · doi:10.1002/hep.1840210219 · Cited by 133
Lazaridis, K. N., Juran, B. D., Boe, G. M., Slusser, J. P., de Andrade, M., Homburger, H. A., Ghosh, K., Dickson, R. E., Lindor, K. D., & Petersen, G. M. (2007) · Hepatology · doi:10.1002/hep.21749 · Cited by 128
Combes, B., Emerson, S. S., Flye, N. L., Muñoz, S. J., Luketic, V. A., Mayo, M. J., McCashland, T. M., Zetterman, R. K., Peters, M. G., Bisceglie, A. M. D., et al. (2005) · Hepatology · doi:10.1002/hep.20897 · Cited by 126
Newton, J. L., Bhala, N., Burt, J., & Jones, D. E. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.012 · Cited by 126
A Prospective Trial of D-Penicillamine in Primary Biliary Cirrhosis
Matloff, D. S., Alpert, E., Resnick, R. H., & Kaplan, M. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198202113060602 · Cited by 124
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis
Leung, P. S. C., Rossaro, L., Davis, P. A., Park, O., Tanaka, A., Kikuchi, K., Miyakawa, H., Norman, G. L., Lee, W., & Gershwin, E. M. (2007) · Hepatology · doi:10.1002/hep.21828 · Cited by 121
D-PENICILLAMINE TREATMENT IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS
Epstein, O., Lee, R., Boss, A. M. B., Jain, S., Cook, D. G., Scheuer, P., & Sherlock, S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92456-9 · Cited by 118
Wolfhagen, F. H. J., van Buuren, H. R., den Ouden, J. W., Hop, W. C. J., van Leeuwen, J. P. T. M., Schalm, S. W., & Pols, H. A. P. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80048-7 · Cited by 116
Colina, F., Pinedo, F., Solis, J. A., Moreno, D. B., & Nevado, M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90771-p · Cited by 116
Ursodeoxycholic Acid for the Treatment of Primary Biliary Cirrhosis
Lindor, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmct074694 · Cited by 115
JONES, D. E. J., & NEWTON, J. L. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03223.x · Cited by 114
Pares, A., Cisneros, L., Salmeron, J. M., Caballeria, L., Mas, A., Torras, A., & Rodes, J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30204.x · Cited by 112
The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine
Van Itallie, T. B., Hashim, S. A., Crampton, R. S., & Tennent, D. M. (1961) · New England Journal of Medicine · doi:10.1056/nejm196109072651004 · Cited by 110
Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.
Neuberger, J., Christensen, E., Portmann, B. C., Caballería, J., Rodés, J., Ranek, L., Tygstrup, N., & Williams, R. L. (1985) · Gut · doi:10.1136/gut.26.2.114 · Cited by 109
Hendrickse, M. T., Rigney, E., Giaffer, M. H., Soomro, I. N., Triger, D. R., Underwood, J. C. E., & Gleeson, D. C. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900400 · Cited by 106
Treatment of primary biliary cirrhosis with low-dose weekly methotrexate
Kaplan, M. M., & Knox, T. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90085-y · Cited by 105
Osteoporosis in primary biliary cirrhosis revisited
Newton, J. L., Francis, R. M., Prince, M., James, O., Bassendine, M. F., Rawlings, D., & Jones, D. (2001) · Gut · doi:10.1136/gut.49.2.282 · Cited by 101
When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
Zein, C. O., Angulo, P., & Lindor, K. D. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1053/cgh.2003.50014 · Cited by 99
A CONTROLLED TRIAL OF D-PENICILLAMINE THERAPY IN PRIMARY BILIARY CIRRHOSIS
Jain, S., Samourian, S., Scheuer, P. J., McGee, J. O., & Sherlock, S. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92778-7 · Cited by 97
Kilmurry, M. R., Heathcote, E. J., Cauch-Dudek, K., O’Rourke, K., Bailey, R. J., Blendis, L. M., Ghent, C. N., Minuk, G. Y., Pappas, S. C., Scully, L. J., et al. (1996) · Hepatology · doi:10.1002/hep.510230532 · Cited by 94
Self-citationNorstrand, M. D. V., Malinchoc, M., Lindor, K. D., Therneau, T. M., Gershwin, E. M., Leung, P. S. C., Dickson, R. E., & Homburger, H. A. (1997) · Hepatology · doi:10.1002/hep.510250103 · Cited by 94
Fracture Risk in People With Primary Biliary Cirrhosis: A Population-Based Cohort Study
Solaymani–Dodaran, M., Card, T. R., Aithal, G. P., & West, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.012 · Cited by 94
Ursodeoxycholic acid for primary biliary cirrhosis
Gong, Y., Huang, Z. B., Christensen, E., & Gluud, C. N. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000551.pub2 · Cited by 94
Accuracy of staging in primary biliary cirrhosis.
Garrido, M. C., & Hübscher, S. G. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.7.556 · Cited by 92
Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression
Dmitrewski, J., Hübscher, S. G., Mayer, A. D., & Neuberger, J. M. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80001-8 · Cited by 92
Muratori, L., Granito, A., Muratori, P., Παππάς, Γ., & Bianchi, F. B. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.009 · Cited by 92
Stojaković, T., Putz‐Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Stadlbauer, V., Gurakuqi, G. C., Stauber, R. E., März, W., & Trauner, M. (2007) · Hepatology · doi:10.1002/hep.21741 · Cited by 90
Role of plasmapheresis in primary biliary cirrhosis.
Cohen, L., Ambinder, E. P., Wolke, A. M., Field, S. P., & Schaffner, F. (1985) · Gut · doi:10.1136/gut.26.3.291 · Cited by 89
Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant
Vleggaar, F. P., van Buuren, H. R., Zondervan, P. E., ten Kate, F. J. W., Hop, W. C. J., & the Dutch Multicentre PBC study group (2001) · Gut · doi:10.1136/gut.49.2.276 · Cited by 87
Huet, P., Vincent, C., Deslaurier, J., Coté, J., Matsutami, S., Boileau, R., & Huet–van Kerckvoorde, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.019 · Cited by 84
Wolfhagen, F. H. J., van Hoogstraten, H. J. F., van Buuren, H. R., Henegouwen, G. P. V. B., ten Kate, F. J. W., Hop, W. C. J., van der Hoek, E. W., Kerbert-Dreteler, M. J., van Lijf, H. H., den Ouden, J. W., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80254-7 · Cited by 83
Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial
Lindor, K. D., Jorgensen, R. A., Tiegs, R. D., Khosla, S., & Dickson, E. R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80118-x · Cited by 79
Effect of different doses of ursodeoxycholic acid in chronic liver disease
Podda, M., Ghezzi, C., Battezzati, P. M., Bertolini, E., Crosignani, A., Petroni, M. L., & Zuin, M. G. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01536665 · Cited by 77
A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis
Kaplan, M. M., Schmid, C. H., Provenzale, D., Sharma, A., Dickstein, G., & McKusick, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70403-8 · Cited by 74
Butler, P., Hamilton-Miller, J. M. T., Baum, H., & Burroughs, A. K. (1995) · PubMed · Cited by 72
From a choleretic to an immunomodulator: Historical review of ursodeoxycholic acid as a medicament
Makino, I., & Tanaka, H. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00707.x · Cited by 67
Mason, A. L., Farr, G. H., Xu, L., Hübscher, S. G., & Neuberger, J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40741.x · Cited by 65
Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment
Parés, A., & Guañabens, N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.005 · Cited by 63
A Prospective Clinical Trial of D–Penicillamine in the Treatment of Primary Biliary Cirrhosis
Bodenheimer, H. C., Schaffner, F., Sternlieb, I., Klion, F. M., Vernace, S. J., & Pezzullo, J. C. (1985) · Hepatology · doi:10.1002/hep.1840050613 · Cited by 61
Transplantation in autoimmune liver diseases
Mottershead, M., & Neuberger, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3388 · Cited by 61
Pruritus in Primary Biliary Cirrhosis: Pathogenesis and Therapy
Bergasa, N. V. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.013 · Cited by 60
Mason, A. L., Lindor, K., Bacon, B. R., Vincent, C., Neuberger, J., & Wasilenko, S. T. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03799.x · Cited by 58
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis
Bogdanos, D. P., Liaskos, C., Parés, A. R., Norman, G. L., Rigopoulou, E. I., Caballería, L., Dalekos, G. Ν., Rodés, J., & Vergani, D. (2007) · Hepatology · doi:10.1002/hep.21678 · Cited by 56
Cost–Effectiveness of Ursodeoxycholic Acid Therapy in Primary Biliary Cirrhosis
Pasha, T. M., Heathcote, J., Gabriel, S. E., Cauch‐Dudek, K., Jorgensen, R. A., Therneau, T. M., Dickson, R. E., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510290116 · Cited by 56
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis
Minuk, G. Y., Böhme, C., Burgess, E. D., Hershfield, N. B., Kelly, J. K., Shaffer, E. A., Sutherland, L. R., & Rosendaal, G. V. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90373-3 · Cited by 56
Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
Fleming, C. R., Ludwig, J., & Dickson, E. R. (1978) · PubMed · Cited by 56
Boone, R. H., Cheung, A. M., Girlan, L. M., & Heathcote, E. J. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-8015-x · Cited by 54
Self-citationSafety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis
Menon, K. V. N., Angulo, P., Boe, G. M., & Lindor, K. D. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07341.x · Cited by 54
Talwalkar, J. A., Angulo, P., & Lindor, K. D. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000177230.13770.4e · Cited by 52
Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study
McCormick, P. A., SCOTT, F. R., Epstein, O., Burroughs, A. K., Scheuer, P. J., & McIntyre, N. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80092-8 · Cited by 51
Pusl, T., Denk, G. U., Parhofer, K. G., & Beuers, U. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.008 · Cited by 50
(1997) · PubMed · Cited by 50
Pereira, S. P., O’Donohue, J., Moniz, C., Phillips, M., Abraha, H. D., Buxton-Thomas, M. S., & Williams, R. L. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01890.x · Cited by 49
Combes, B., Luketic, V. A., Peters, M. G., Zetterman, R. K., García–Tsao, G., Muñoz, S. J., Lin, D.-Y., Flye, N. L., & Carithers, R. L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04047.x · Cited by 49
Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community
Pla, X., Vergara, M., Gil, M., Dalmau, B., Cisteró, B., Bella, R. M., & Real, J. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328277594a · Cited by 46
Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis
Hirschfield, G. M., & Heathcote, E. J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.003 · Cited by 46
Self-citationResults of long-term ursodiol treatment for patients with primary biliary cirrhosis
Jorgensen, R. A., Angulo, P., Dickson, E. R., & Lindor, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06043.x · Cited by 46
Long‐term follow‐up of patients with primary biliary cirrhosis on colchicine therapy
Zifroni, A., & Schaffner, F. (1991) · Hepatology · doi:10.1002/hep.1840140607 · Cited by 44
Walker, L. J., Newton, J. L., Jones, D. E. J., & Bassendine, M. F. (2008) · Hepatology · doi:10.1002/hep.22670 · Cited by 43
Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?
Krzeski, P., Zych, W., Kraszewska, E., Milewski, B., Butruk, E., & Habior, A. (1999) · Hepatology · doi:10.1002/hep.510300415 · Cited by 42
The pathology of primary biliary cirrhosis and autoimmune cholangitis
Ludwig, J. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2000.0106 · Cited by 42
Mortality attributable to cholestatic liver disease in the United States†
Mendes, F. D., Kim, W. R., Pedersen, R. A., Therneau, T. M., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22178 · Cited by 41
Gong, Y., & Gluud, C. N. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41522.x · Cited by 41
Siegel, J. L., Jorgensen, R., Angulo, P., & Lindor, K. D. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200308000-00018 · Cited by 40
Long‐term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow‐up to 12 years
Chan, C.-W., Günşar, F., Feudjo, M., Rigamonti, C., Vlachogiannakos, J., Carpenter, J. R., & Burroughs, A. K. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02318.x · Cited by 37
Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis
Guañabens, N., Parés, A. R., Navasa, M., de Osaba, M. J. M., Hernández, M. E., Muñoz, J., & Rodés, J. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80132-0 · Cited by 37
D-penicillamine for primary biliary cirrhosis
Gong, Y., Klingenberg, S. L., & Gluud, C. N. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004789.pub2 · Cited by 36
Recent Advances in the Epidemiology of Primary Biliary Cirrhosis
Gross, R. G., & Odin, J. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.001 · Cited by 34
Prediction of short‐term survival with an application in primary biliary cirrhosis
Hughes, M. D., Raskino, C., Pocock, S., Biagini, M. R., & Burroughs, A. K. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111307 · Cited by 34
Benetti, A., Crosignani, A. L., VARENNA, M., Giussani, C., Allocca, M., Zuin, M. G., Podda, M., & Battezzati, P. M. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000248017.31386.39 · Cited by 32
Presentation and mortality of primary biliary cirrhosis in older patients
Newton, J. L. (2000) · Age and Ageing · doi:10.1093/ageing/29.4.305 · Cited by 31
Taal, B. G., Schalm, S. W., ten Kate, F. J. W., Henegouwen, G. P. V. B., & Brandt, K. ‐. (1983) · Liver International · doi:10.1111/j.1600-0676.1983.tb00887.x · Cited by 28
Natural history of primary biliary cirrhosis
Abe, M., & Onji, M. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00351.x · Cited by 26
Cyclosporin A for primary biliary cirrhosis
Gong, Y., Christensen, E., & Gluud, C. N. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005526.pub2 · Cited by 22
Chan, C.-W., Carpenter, J. R., Rigamonti, C., Gunsar, F., & Burroughs, A. K. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510023215 · Cited by 17
Bhat, M., Guindi, M. M., Heathcote, E. J., & Hirschfield, G. M. (2008) · Gut · doi:10.1136/gut.2008.163220 · Cited by 15
Self-citationThe serology of the Addison-Gull syndrome
Reuben, A. (2003) · Hepatology · doi:10.1002/hep.510370134 · Cited by 14
Heathcote, J. E., Cauch-Dudek, K., Walker, V., Bailey, R. J., Blendis, L. M., Ghent, C. N., Michieletti, P., Minuk, G. Y., Pappas, C. S., Scully, L. J., et al. (1994) · Hepatology · doi:10.1002/hep.1840190512 · Cited by 2
Research works printed but not linked: 1
- 10.1002/hep.1840220311 · doi:10.1002/hep.1840220311 · Paper page
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationBoberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
Self-citationNew paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
Hepatocyte Death: A Clear and Present Danger
Malhi, H., Guicciardi, M. E., & Gores, G. J. (2010) · Physiological Reviews · doi:10.1152/physrev.00061.2009 · Cited by 477
Corpechot, C., Chazouillères, O., & Poupon, R. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.031 · Cited by 460
Metadata
- Authors
- Hirschfield, G. M., & Heathcote, E. J.
- Venue
- Evidence‐Based Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2010-07-22
- Pages
- 508-523
- OpenAlex
- W3022109954
- Cited by
- 261
- References
- 156
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.